Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 50268-096, ATORVASTATIN CALCIUM, tablet, film coated, from AvPAK.

Product NDC
50268-096
Status
Listed
Labeler
AvPAK
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090548
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50268-096 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE80 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
50268-096-125026800961220 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-096-12) / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-096-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b687ba81-cb24-bbdf-5dd9-ab0e53dd480b
  • NADAC price for package 50268009612

    GET /v1/drugs/nadac/50268009612

Use it

Look up 50268-096 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50268-096 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50268-096. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.